Vanguard Personalized Indexing Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Buy
18,407
+4,398
+31% +$65.4K ﹤0.01% 1807
2026
Q1
$215K Sell
14,009
-820
-6% -$13.7K ﹤0.01% 1781
2025
Q4
$268K Buy
14,829
+782
+6% +$13.5K ﹤0.01% 1582
2025
Q3
$226K Buy
14,047
+716
+5% +$10.5K ﹤0.01% 1635
2025
Q2
$145K Buy
13,331
+2,832
+27% +$31.7K ﹤0.01% 1686
2025
Q1
$131K Sell
10,499
-2,302
-18% -$37.9K ﹤0.01% 1577
2024
Q4
$253K Buy
+12,801
New +$142K ﹤0.01% 1414
2023
Q3
Sell
-6,269
Closed -$49K 1527
2023
Q2
$49K Buy
6,269
+7
+0.1% +$50 ﹤0.01% 1427
2023
Q1
$41.2K Buy
+6,262
New +$41.4K ﹤0.01% 1431
2022
Q1
Sell
-5,478
Closed -$53K 1221
2021
Q4
$53K Buy
+5,478
New +$63.7K ﹤0.01% 1044

Other funds holding MESO

Vanguard Personalized Indexing Management's MESO Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Mesoblast (MESO) stake by 31% in Q2 2026, buying an estimated $65.4K and bringing the position to 18,407 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Vanguard Personalized Indexing Management first reported a position in MESO in Q4 2021 and has held it in 10 quarters since. The position peaked at $268K in Q4 2025. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Vanguard Personalized Indexing Management held 18,407 shares of Mesoblast worth $249K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 4,398 Mesoblast shares in Q2 2026, an estimated $65.4K.
  • Mesoblast made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1807 holding.
  • Vanguard Personalized Indexing Management first reported a position in Mesoblast in Q4 2021 and has held it in 10 quarters since.
  • Vanguard Personalized Indexing Management's Mesoblast position peaked at $268K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.